Stax Advises Pfingsten Partners on its Investment in Fowler High Precision

Stax Advises Pfingsten Partners on its Investment in Fowler High Precision

September 5, 2022
September 5, 2022

Share

Stax congratulates Pfingsten Partners on its recent investment in Fowler High Precision, a manufacturer and distributor of inspection, control, and calibration equipment.

 

Fowler High Precision’s primary focus is the manufacturing and innovation of precision tools, which they sell through their network of industrial distributors along the East and West coasts. Brand partnerships include zCAT—a subsidiary of Fowler High Precision, digital measuring systems producer Sylvac, and Swedish spirit level manufacturer Wyler.

Stax provided Pfingsten Partners with commercial due diligence support on this transaction.  

For more details on our experience in the space, please contact the Stax team:

PSG logo
PSG logo
Image of Roy Lockhart

Roy Lockhart

Managing Director

About Stax

Stax is a global management consulting firm serving corporate and private equity clients across a broad range of industries including software/technology, industrials, business and information services, healthcare and HCIT, consumer, and tradeshows and events. 

Read More

Featured by Bezinga: Health Care PE Is ‘No Longer An Easy Source Of Returns'
October 8, 2026
Rob Larson was featured by Bezinga, offering his expert insights on the current state of healthcare within PE and why investments continue to be made in the industry, Read more.
What Local Governments Need from GovTech Right Now: Lessons from CivStart
By Chen Liu • October 1, 2026
Partner Chen Liu attended CivStart's GovTech conference, sharing his insights and key takeaways on what GovTech providers and investors should know. Read more.
Grant Thornton Stax Top 20 2025
By Florent Jarry & David Lindsay • September 17, 2026
Grant Thornton Stax has released its annual Top 20 Ranking of Exhibition Organizers. Click here to explore the full list.
Feat. by Pitchbook: The future of diligence is not integration. It is conviction.
By Paul Edwards • September 15, 2026
Global Practice Leader Paul Edwards explains how diligence is changing and how confidence and conviction are adding exit value. Read the full article here.
Featured by Carta: PE is trying to figure out where AI fits into the future of healthcare
By Rob Larson • September 8, 2026
Rob Larson met with Carta to discuss the growing problem of supply and demand in the US healthcare system, and how a technological revamp could be necessary. Read the full feature here.
Grant Thornton Stax  Sell-side: Outcomes Strategic Investment From H.I.G. Capital
September 2, 2026
Grant Thornton Stax supported Outcomes, a leading provider of clinical network services and pharmacy technology, on its recent acquisition by H.I.G. Capital. Read more.
Show More